| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/12/1992 | EP0470514A1 Carbostyril derivatives and pharmaceutical composition containing the same |
| 02/12/1992 | EP0470490A1 Substituted pyrroles |
| 02/11/1992 | US5087630 Method for the treatment of a hyponatremic disease |
| 02/11/1992 | US5087629 Pharmacologically active pyrazolopyridine compounds |
| 02/11/1992 | US5087613 Hirudin variants |
| 02/11/1992 | US5087572 Anticoagulants |
| 02/11/1992 | CA1295615C 2-amino-3-aroyl- -oxobenzenebutanoic acids and esters |
| 02/11/1992 | CA1295552C Use of iron(iii) phosphate compounds for iron fortification of food products |
| 02/09/1992 | CA2048714A1 Acid addition salts of optically active alaninanilide compounds and pharmaceutical compositions containing the same |
| 02/07/1992 | WO1992002239A1 Stable hemoglobin based composition and method to store same |
| 02/06/1992 | WO1992001794A2 Ancrod-like proteins, their preparation and their use |
| 02/06/1992 | WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 02/06/1992 | WO1992001710A1 Anticoagulant peptides |
| 02/05/1992 | EP0469901A1 Sulfonamide derivatives |
| 02/05/1992 | EP0468971A1 Novel benzimidazole derivatives |
| 02/05/1992 | CN1058342A Soluble hemostyptic fabric |
| 02/05/1992 | CN1015361B Enantiomeric glutaramide diuretic agents |
| 02/04/1992 | WO1992004895A1 Enhancement of glutathione levels with glutamine |
| 02/04/1992 | US5086070 4-benzyl-1h-indoles and anti-arrthymic use thereof |
| 02/04/1992 | US5086057 Method of treating cachexia and certain new compounds for use in this method |
| 01/30/1992 | DE4023699A1 Neue proteine, ihre herstellung und verwendung New proteins, their production and use |
| 01/29/1992 | EP0468764A1 Method for administering a therapeutic anticoagulant |
| 01/29/1992 | EP0468497A2 Peptide-antagonists of bombesin/GRP |
| 01/29/1992 | EP0468448A2 Analogs of hirudin having antiplatelet activity |
| 01/29/1992 | EP0468327A2 Oral pharmaceutical compositions containing hirudin |
| 01/29/1992 | EP0468281A1 Substituted phenylacetylenes, pharmaceuticals containing them and methods for the preparation of these compounds and pharmaceuticals |
| 01/29/1992 | EP0468231A2 Guanidins |
| 01/29/1992 | EP0468181A2 Process for the purification of factor VIII and factor VIII obtained by said process |
| 01/29/1992 | EP0468114A2 Soluble haemostatic fabric |
| 01/29/1992 | EP0468054A1 Benzenesulfonamide derivative |
| 01/29/1992 | EP0467991A1 Platelet membrane microparticles |
| 01/29/1992 | EP0467987A1 Methods and materials for expression of human plasminogen in a eukaryotic cell system |
| 01/29/1992 | EP0467932A1 Urokinase-type plasminogen activator receptor |
| 01/28/1992 | US5084564 Ultrafiltration of heparin through a membrane, partitioning and depolymerization |
| 01/28/1992 | US5084469 New substituted benzothiazolinones |
| 01/28/1992 | US5084466 Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| 01/28/1992 | US5084444 Anticoagulants and enzyme inhibitors |
| 01/28/1992 | US5084274 Inhibition of arterial thrombotic occlusion or thromboembolism |
| 01/28/1992 | US5084273 Composition of anticoagulants |
| 01/28/1992 | CA1294967C Derivatives of 1h, 3h-pyrrolo [1,2-c] thiazole, their preparation and pharmaceutical compositions containing them |
| 01/28/1992 | CA1294966C Drivatives of 1h, 3h-prorrolo [1,2-c] thiazole, their preparation and pharmaceutical compositions containing them |
| 01/27/1992 | CA2043823A1 Substituted phenylacetylenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions |
| 01/25/1992 | WO1992001712A1 Analogs of hirudin |
| 01/25/1992 | CA2066749A1 Analogs of hirudin |
| 01/25/1992 | CA2047527A1 Method for administering a therapeutic anticoagulant |
| 01/23/1992 | WO1991019793A3 Hybrid plasminogen activators |
| 01/22/1992 | EP0467248A2 Pyrazolopyridine compound and processes for preparation thereof |
| 01/22/1992 | EP0466780A1 Megakaryocyte growth promoting activity |
| 01/21/1992 | US5082859 Derivatives of benzocycloalkenyldihydroxyalkanoic acids and medications containing them |
| 01/21/1992 | US5082839 Platelet activating factor antagonist |
| 01/21/1992 | CA1294623C Decahydroquinolein derivatives, preparation process for same and new intermediates obtained, their application as medications and pharmaceuticals containing such |
| 01/15/1992 | EP0466199A1 Polypeptide fragments of factor VIIIc, corresponding probes and DNA sequences and DNA constructs |
| 01/15/1992 | EP0466174A1 Novel physiologically active porcine peptide (CNP-53) |
| 01/15/1992 | CN1057839A Azabenzimidazoles in treatment of asthma, arthritis and related diseases |
| 01/14/1992 | WO1992001039A1 Promotion of maturation of hematopoietic progenitor cells |
| 01/14/1992 | US5081282 Prostaglandins |
| 01/14/1992 | CA2087170A1 Promotion of maturation of hematopoietic progenitor cells |
| 01/10/1992 | WO1992000995A1 Cyclic cell adhesion modulation compounds |
| 01/10/1992 | CA2087021A1 Cyclic cell adhesion modulation compounds |
| 01/08/1992 | EP0465358A1 2-Thienylglycidic acid derivative, process for its preparation and its use as synthetic intermediate |
| 01/08/1992 | EP0465097A2 Peptides having atrial natriuretic factor activity |
| 01/08/1992 | EP0464533A1 Fusionproteins with parts of immunoglobulins, their production and use |
| 01/08/1992 | EP0464521A2 Polysulfide compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient |
| 01/08/1992 | CN1057649A 2,4-and 2,5-substituted pyridine-n-oxides, process for their preparation and their use |
| 01/07/1992 | US5079337 Transfusions of synthetic blood; nondiffusing from vascular systems; reversible oxygen carriers |
| 01/07/1992 | US5079258 Enzyme inhibitors, antiallergens treatment of asthma |
| 01/07/1992 | US5079247 N1 -substituted benz(cd)indol-2-imine compounds as cardiovascular agents |
| 01/07/1992 | CA1293941C Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product |
| 01/06/1992 | CA2044636A1 Guanidines |
| 01/03/1992 | WO1992000319A1 Human meg-csf protein and methods |
| 01/03/1992 | CA2086248A1 Human meg-csf protein and methods |
| 01/02/1992 | EP0463945A1 Chalcone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/02/1992 | EP0463944A1 Acylbenzoxazolinones, process for their preparation and pharmaceutical compositions containing them |
| 01/02/1992 | EP0463636A2 Cardiovascular composition |
| 01/02/1992 | EP0463592A1 2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and for their utilization |
| 01/02/1992 | EP0463393A2 A mutant of bacillus subtiles and a method of producing surfactin with the use of the mutant |
| 01/02/1992 | EP0463162A1 PREPARATION OF 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES |
| 01/01/1992 | CN1057461A Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents |
| 01/01/1992 | CN1057458A Amino bicyclic compounds |
| 01/01/1992 | CN1057390A Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use |
| 12/31/1991 | US5077285 Imidazole compounds and their use as transglutaminase inhibitors |
| 12/31/1991 | US5077281 Novel use of taurolin |
| 12/31/1991 | CA1293728C Ascorbic acid derivatives, production and use thereof |
| 12/30/1991 | WO1992000290A1 Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones |
| 12/30/1991 | CA2064796A1 Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones |
| 12/29/1991 | CA2045868A1 2,4- and 2,5-substituted pyridine-n-oxides, processes for their preparation and their use |
| 12/27/1991 | EP0462960A1 Novel platelet-aggregation inhibitor |
| 12/27/1991 | EP0462766A1 Composition useful in thrombolytic therapy |
| 12/27/1991 | EP0462761A2 Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents |
| 12/27/1991 | EP0462651A1 Chimeric plasminogen activators |
| 12/27/1991 | EP0462556A2 Hypotriglyceridemic use of certain bis(3,5-di-alkyl-4-hydroxphenylthio)methanes |
| 12/27/1991 | EP0462506A1 Pharmaceutical preparations of mixtures comprising cefotaxim and derivatives of xanthine and their use |
| 12/27/1991 | EP0462264A1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications as paf-antagonists. |
| 12/27/1991 | EP0462207A1 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression |
| 12/27/1991 | CA2045420A1 Peptides having atrial natriuretic factor activity |
| 12/26/1991 | WO1991019734A2 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 12/26/1991 | WO1991019514A1 An anticoagulant preparation |
| 12/26/1991 | WO1991019495A1 Use of a macrolide compound such as fk 506 for manufacturing a medicament for treating idiopathic thrombocytopenic purpura and basedow's disease |
| 12/26/1991 | CA2574895A1 Nucleic acid ligands |
| 12/26/1991 | CA2085101A1 An anticoagulant preparation |